org placeholder image

Tate Owen

Associate Director, Dmpk at Regulus Therapeutics

  • LinkedIn

Email Email: t****@regulusrx.com

phone noPhone Number: (***)-***-****

map
REGULUS THERAPEUTICS

REGULUS THERAPEUTICS

  • description Description
    Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleo...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Regulus Therapeutics Org Chart and Mapping

Employees

Genna Boragine

Scientist II, Analytical Development

Morgan Carlson

Vice President, Biology

Edmund Lee

Vice President (Translational Medicine)

James Nilsen

Sr. Accountant, Financial Reporting & Sox Compliance

Mark Flores

Talent Acquisition Consultant (Contract Role)

Daniel Penksa

Executive Director Finance & Controller

Zhi Chu

Founder, CEO and CSO

Frequently Asked Questions Regarding Tate Owen

Answer: Tate Owen works for Regulus Therapeutics as Associate Director, Dmpk

Answer: Tate Owen’s role in Regulus Therapeutics is Associate Director, Dmpk

Answer: Tate Owen's email address is t***@gmail.com

Answer: Tate Owen's business email address is t****@regulusrx.com

Answer: Tate Owen’s direct phone number is (***)-***-****

Answer: Tate Owen works in the industry of: Biotechnology

Answer: Tate Owen works Regulus Therapeutics located at 3700 O St Nw, San Diego, California, 20057, United States

Answer: Regulus Therapeutics's Associate Director, Dmpk is Tate Owen

Answer: Tate Owen contact details:

  • Phone number  :  (***)-***-****
  • Email  :  t****@regulusrx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access